Rubric Capital Management LP
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1687509
NEW YORK, NY
Position in ARQT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$216,880,748
+$22,002,394 QoQ
Shares Held
8,271,577
0.0% QoQ
Ownership
6.58%
of shares outstanding
% of Portfolio
1.99%
of 13F equity value
Holder Rank
#4
of 269 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rubric Capital Management LP holds $1,431,610,576 across 20 Biotechnology names. ARQT ranks #1 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
8,271,577 | $216,880,748 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
6,000,000 | $212,340,000 | |
| 3 | ZYME |
Zymeworks Inc.
|
7,000,000 | $182,980,000 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
7,227,778 | $175,345,894 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
9,100,000 | $122,941,000 | |
| 6 | ARDX |
Ardelyx, Inc.
|
16,202,700 | $82,633,770 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
9,339,414 | $78,170,895 | |
| 8 | MNKD |
Mannkind Corp
|
18,000,000 | $76,680,000 |
All Filings in ARQT
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $216,880,748 | 8,271,577 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $194,878,354 | 8,271,577 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $240,206,596 | 8,271,577 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $202,627,264 | 10,749,457 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $150,707,387 | 10,749,457 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $171,518,750 | 10,966,672 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $152,765,740 | 10,966,672 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $101,990,049 | 10,966,672 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $91,295,049 | 9,816,672 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $74,424,100 | 7,510,000 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $21,461,831 | 6,644,530 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $26,733,354 | 5,034,530 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $46,549,570 | 4,884,530 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $38,500,000 | 3,500,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $40,589,281 | 2,742,519 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $9,020,818 | 472,047 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,823,433 | 226,346 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||